Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females

Journal of Neurosurgery

Volumn 118, Issue 3, 2013, Pages 649-656

  Claus, Elizabeth B ^a,e   Calvocoressi, Lisa ^a   Bondy, Melissa L ^b   Wrensch, Margaret ^d   Wiemels, Joseph L ^d   Schildkraut, Joellen M ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Body mass index; Breastfeeding; Epidemiology; Hormone replacement therapy; Hormones; Meningioma; Oncology; Oral contraceptives; Reproductive variables; Smoking

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BODY MASS; BREAST FEEDING; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; GROUPS BY AGE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL GEOGRAPHY; MENARCHE; MENINGIOMA; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; UNITED STATES;

ADULT; AGE OF ONSET; AGED; BODY MASS INDEX; BREAST FEEDING; CONNECTICUT; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MASSACHUSETTS; MENARCHE; MENINGEAL NEOPLASMS; MENINGIOMA; MENOPAUSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORTH CAROLINA; ODDS RATIO; PARITY; REGISTRIES; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; SAN FRANCISCO; SMOKING; TEXAS;

EID: 84874599788     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.9.JNS12811     Document Type: Article

References (31)

1. Baron JA, La Vecchia C, Levi F: The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 162: 502-514, 1990
2. Benson VS, Pirie K, Green J, Bull D, Casabonne D, Reeves GK, et al: Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer 127:1692-1698, 2010
3. Benson VS, Pirie K, Green J, Casabonne D, Beral V: Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 99:185-190, 2008
4. Blitshteyn S, Crook JE, Jaeckle KA: Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 26:279-282, 2008
5. Cea-Soriano L, Blenk T, Wallander MA, Rodríguez LAG: Hormonal therapies and meningioma: Is there a link? Cancer Epidemiol 36:198-205, 2012
6. Central Brain Tumor Registry of the United States: CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. (http://www.cbtrus.org/2011-NPCR-SEER/WEB-0407-Report-3-3- 2011.pdf) [Accessed September 24, 2012]
7. Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M: Family and personal medical history and risk of meningioma. Clinical article. J Neurosurg 115:1072-1077, 2011
8. Claus EB, Park PJ, Carroll R, Chan J, Black PM: Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 68:314-322, 2008
9. Claus EB, Walsh K, Calvocoressi L, Bondy M, Schildkraut J, Wrensch M, et al: Cigarette smoking and risk of meningioma: The effect of gender. Cancer Epidemiol Biomark Prev 21: 943-950, 2012
10. Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, Lebailly P, et al: Brain tumors and hormonal factors: Review of the epidemiological literature. Cancer Causes Control 22: 697-714, 2011
11. Custer BS, Koepsell TD, Mueller BA: The association between breast carcinoma and meningioma in women. Cancer 94:1626-1635, 2002
12. Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G: Hormonal exposures and the risk of intracranial meningioma in women: A population-based case-control study. BMC Cancer 6:152, 2006
13. De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, et al: Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol 8:145-155, 2006
14. De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, et al: Genetic polymorphisms in GSTM1,-P1,-T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 12:14-22, 2003
15. Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, et al: Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114:797-805, 2005
16. Hersh AL, Stefanick ML, Stafford RS: National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 291:47-53, 2004
17. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ: Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848-853, 2003
18. Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, et al: Risk factors for meningioma in postmenopausal women: Results from the Iowa Women's Health Study. Neuro Oncol 13:1011-1019, 2011
19. Korhonen K, Auvinen A, Lyytinen H, Ylikorkala O, Pukkala E: A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland. Am J Epidemiol 175:309-314, 2012
20. Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A: Exogenous sex hormone use and risk of meningioma: A population-based case-control study in Finland. Cancer Causes Control 21:2149-2156, 2010
21. Lambe M, Coogan P, Baron J: Reproductive factors and the risk of brain tumors: A population-based study in Sweden. Int J Cancer 72:389-393, 1997
22. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F: Association of meningioma with reproductive factors. Int J Cancer 119:1152-1157, 2006
23. Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, et al: Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562-2569, 2010
24. Sandini L, Pentti K, Tuppurainen M, Kröger H, Honkanen R: Agreement of self-reported estrogen use with prescription data: An analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study. Menopause 15:282-289, 2008
25. Schwartzbaum JA, Ahlbom A, Lönn S, Warholm M, Rannug A, Auvinen A, et al: An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev 16:559-565, 2007
26. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, et al: Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82:155-160, 1999
27. Wiemels J, Bracchi P, Schildkraut J, Wrensch M, Bondy M, Pfefferle J, et al: Effect of gender on the production of autoantibodies to meningioma antigens. Am J Epidemiol [in press], 2012
28. Wiemels JL, Wrensch M, Claus EB: Epidemiology and etiology of meningioma. J Neurooncol 99:307-314, 2010
29. Wiemels JL, Wrensch M, Sison JD, Zhou M, Bondy M, Calvocoressi L, et al: Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer 129:1932-1939, 2011
30. Wigertz A, Lönn S, Hall P, Auvinen A, Christensen HC, Johansen C, et al: Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 17: 2663-2670, 2008
31. Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, Feychting M: Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164:629-636, 2006